Quick answers
- What is Cleocin Phosphate?
- Cleocin Phosphate is a brand name of Clindamycin, a prescription medicine. The FDA NDC Directory lists 12 Cleocin Phosphate products in 1 strength and form.
- Who makes Cleocin Phosphate?
- Pfizer holds the FDA application for Cleocin Phosphate (NDA050441, approved October 2, 1972). 3 other companies (repackagers or distributors) also list Cleocin Phosphate products.
- Is there a generic or store brand of Cleocin Phosphate?
- Yes. The FDA NDC Directory lists 6 other products with the same active ingredients, strength and form as a Cleocin Phosphate product, 6 of them generic. Ask your pharmacist whether one is right for you.
- Has Cleocin Phosphate been recalled?
- FDA enforcement reports list 4 recalls of Cleocin Phosphate products; the newest started March 15, 2019. A recall usually concerns specific lots, not every product.
What Cleocin Phosphate is
Each Cleocin Phosphate product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Clindamycin · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| clindamycin phosphate 150 mg/mL injection, solution (intramuscular, intravenous) | Cleocin Phosphate | 6 products, 3 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Clindamycin →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA050441 | Pfizer | October 2, 1972 | 12 |
Companies that list Cleocin Phosphate
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Cleocin Phosphate products.
- Pharmacia & Upjohn Company LLC6 products
- Medical Purchasing Solutions, LLC4 products
- ProPharma Distribution1 product
- Henry Schein, Inc.1 product
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
March 15, 2019 · Class III · Terminated · D-1067-2019
Failed Impurities/Degradation Specifications: High out-of-specification (OOS) results were demonstrated for several specified impurities at the 24-month time point
Cleocin Phosphate (clindamycin injection), USP, 300 mg/ 2 mL (150 mg/mL), 2 mL-vial, Rx only, Distributed by Pharmacia & Upjohn Co, Division of Pfizer, Inc, New York, NY 10017, NDC 0009-6582-02 — Pfizer Inc.
-
March 15, 2019 · Class III · Terminated · D-1069-2019
Failed Impurities/Degradation Specifications: High out-of-specification (OOS) results were demonstrated for several specified impurities at the 24-month time point
Cleocin Phosphate, clindamycin injection, USP, 900 mg/ 6 mL (150 mg/mL), 6 mL vial, Rx only, Distributed by Pharmacia & Upjohn Co, Division of Pfizer, Inc, New York, NY 10017. NDC 0009-3447-01 — Pfizer Inc.
-
March 15, 2019 · Class III · Terminated · D-1068-2019
Failed Impurities/Degradation Specifications: High out-of-specification (OOS) results were demonstrated for several specified impurities at the 24-month time point
Cleocin Phosphate, clindamycin injection, USP, 600 mg/ 4 mL (150 mg/mL), 4 mL vial, Rx only, Distributed by Pharmacia & Upjohn Co, Division of Pfizer, Inc, New York, NY 10017, NDC 0009-3124-01 — Pfizer Inc.
-
June 4, 2013 · Class II · Terminated · D-609-2013
Presence of Particulate Matter: Firm is recalling a small number of vials with very small reflective flakes consistent with delamination of the glass vial.
Cleocin Phosphate (clindamycin Injection), USP, a) 600 mg/4mL (150 mg/mL) ADD-Vantage Vial, b) 900 mg/6mL (150 mg/mL) ADD-Vantage Vial, Rx Only, For Intravenous Use Only, Use Only with the ADD-Vantage diluent container, — Pharmacia & Upjohn LLC
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.